Has Ramanjot Kang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,472 in general payments to Ramanjot Kang, MD across 185 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ramanjot Kang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ramanjot Kang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ramanjot Kang, MD

Pain Medicine · White Plains, NYNPI 1457855314

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.2%), travel and lodging and grants — rather than concentrated in one kind of arrangement. Medtronic accounts for 66.3% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2023 at $6,735 and has fallen 58.6% since, to $2,788 in 2025. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,472in general payments, 2019–2025

Across 185 payments — averaging $116.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$14K
Abbott$3K
MML US, Inc.$800
Boston Scientific$787
Relievant Medsystems, Inc.$571
AbbVie$442
plus $2K from 17 others

What the payments were for

Grants$3,62517%
Travel & lodging$8,35739%
Food & beverage$9,49044%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	117	$14,235
Abbott	11	$2,825
MML US, Inc.	10	$800
Boston Scientific	8	$787
Relievant Medsystems, Inc.	3	$571
AbbVie	3	$442
Nalu Medical, Inc.	7	$355
Saluda Medical Americas, Inc.	2	$237
SPR Therapeutics, Inc	3	$222
Si-bone, Inc.	2	$200
Curonix LLC	3	$135
Intercept Pharmaceuticals, Inc.	1	$129
E.r. Squibb & Sons, L.L.C.	1	$109
Takeda Pharmaceuticals U.S.A., Inc.	1	$108
Nevro Corp.	2	$79
Spinal Simplicity, LLC	2	$58
Collegium Pharmaceutical, Inc.	2	$36
Pacira Pharmaceuticals Incorporated	1	$36
Scilex Pharmaceuticals Inc.	2	$32
Bioventus LLC	1	$28
Stryker	1	$18
Chiesi USA, Inc.	1	$16
Globus Medical	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTELLIS ADAPTIVESTIM$4,497
SYNCHROMEDII$4,259
Intracept$2,186
PROCLAIM$1,271
VANTA ADAPTIVESTIM$1,214
KYPHON EXPRESS II KYPHOPAK TRAY$1,157
ReActiv8$735
INCEPTIV$551
Superion Indirect Decompression System$317
Skyrizi$292
ETERNA$276
WaveWriter Alpha Prime 16$272
Nalu Neurostimulation System$221
Evoke SCS$160
Rinvoq$150
OCALIVA$129
ZEPOSIA$109
GATTEX$108
SPRINT PNS System$103

How this compares

$21,472 in reported general payments places this provider in the 90th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York →

Medicare billing

Part B allowed, 2024

$105,553

Medicare patients

185

Services billed

1,386

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	56	$1,000
Gabapentin	61	$525
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	21	$327
Cyclobenzaprine Hcl	32	$246
Tramadol Hcl	53	$240
Acetaminophen-CodeineAcetaminophen With Codeine	16	$220
Celecoxib	21	$182
Tizanidine Hcl	17	$130
Meloxicam	61	$129
Methylprednisolone	14	$96
Alprazolam	15	$7

Paid to pharmacies, not to this prescriber.

Other pain medicine in White Plains

Gary SchwartzBrooklyn$756K
Amitabh GulatiNew York$614K
William CaldwellStony Brook$530K
Brian DurkinPort Jefferson$455K
David SpinnerNew York$391K
Grace FordeNew Hyde Park$355K
Romanth WaghmaraeHamburg$158K
Samuel BrownSouthold$147K
Fred CohenBronx$141K
Eric LeeNew York$117K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →